Two Sigma Securities, LLC Ardelyx, Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.23 - $4.95 $30,349 - $46,510	-9,396 Reduced 38.95%	14,726 $49,000
Q1 2023 May 15, 2023	SELL	$2.68 - $4.79 $7,343 - $13,124	-2,740 Reduced 10.2%	24,122 $115,000
Q4 2022 Feb 14, 2023	SELL	$1.22 - $2.85 $5,153 - $12,038	-4,224 Reduced 13.59%	26,862 $76,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $18,340 - $44,763	31,086 New	31,086 $37,000
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $81,554 - $148,053	-125,469 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $54,574 - $107,880	63,459 Added 102.34%	125,469 $138,000
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $78,752 - $506,621	62,010 New	62,010 $82,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.